Integrating Emerging Research into Biofilm Management is organized by Healthcare Made Practical (HMP) Communications LLC.
Release Date: September 28, 2018
Expiration Date: September 28, 2019
Intended Audience:
This activity is designed for physicians, podiatrists, and nurses.
Accreditation:
CME:
NACCME designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants:
NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 credit.
CNE:
This continuing nursing education activity awards 1.0 contact hour.
CPME:
NACCME has approved this activity for a maximum of 1.0 continuing education contact hour.
Learning Objectives:
After completing this activity, participants should be able to:
• Investigate emerging research regarding the paradigm shift from simply killing surface bacteria to penetrating the biofilm's EPS
• Examine the clinical and economic advantages of leveraging biofilm-disrupting technology
• Assess the efficacy of a novel biofilm disruption therapy in the treatment of chronic wounds compared to standard of care
• Explore cases for the use of a high osmolarity biofilm disrupting surfactant to decrease bioburden and inflammation in non-healing chronic wounds.
Additional details will be posted as soon as they are available.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved